Evidence map›Paper›PMID 39821078›Full record

ArticleApplied microbiology and biotechnology2025

Microaerobic biodegradation of aromatic hydrocarbon mixtures: strategies for efficient nitrate and oxygen dosage.

Dilan Camille Aydin, Andrea Aldas-Vargas, Tim Grotenhuis, Huub Rijnaarts

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dilan Camille AydinDepartment of Environmental Technology, Wageningen University & Research, P.O. Box 17, 6700 AA, Wageningen, The Netherlands. dilanc.aydin@gmail.com.ORCID http://orcid.org/0000-0002-3457-1368
Andrea Aldas-VargasDepartment of Environmental Technology, Wageningen University & Research, P.O. Box 17, 6700 AA, Wageningen, The Netherlands.
Tim GrotenhuisDepartment of Environmental Technology, Wageningen University & Research, P.O. Box 17, 6700 AA, Wageningen, The Netherlands.
Huub RijnaartsDepartment of Environmental Technology, Wageningen University & Research, P.O. Box 17, 6700 AA, Wageningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biodegradation of organic aromatic compounds in subsurface environments is often hindered by limited dissolved oxygen. While oxygen supplementation can enhance in situ biodegradation, it poses financial and technical challenges. This study explores introducing low-oxygen concentrations in anaerobic environments for efficient contaminant removal, particularly in scenarios where coexisting pollutants are present. An innovative strategy of alternating nitrate-reducing and microaerobic conditions to stimulate biodegradation is proposed, utilizing nitrate initially to degrade easily-degradable compounds, and potentially reducing the need for additional oxygen. Batch experiments were conducted to assess the biodegradation of a BTEX, indene, indane, and naphthalene mixture using groundwater and sediments from an anaerobic contaminated aquifer. Two set-ups were incubated for 98 days to assess the redox transitions between microaerobic (oxygen concentrations < 0.5 mg O

Indexed as

Hydrocarbons, AromaticNitratesOxygenWater Pollutants, ChemicalAerobiosisAnaerobiosisBiodegradation, EnvironmentalGroundwaterNaphthalenesOxidation-ReductionHydrocarbons, AromaticnaphthaleneNaphthalenesNitratesOxygenWater Pollutants, ChemicalBioremediationBTEXMicroaerobic conditionsNitrate-reducing conditionsOxygen supplementationRedox transitions

Identifiers

PMID39821078
PMCPMC11739264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.